Cargando…

PM389. Preliminary Genetic Model Predicting Clozapine Response

Detalles Bibliográficos
Autores principales:	Huang, Eric, Kennedy, James, Lieberman, Jeffrey, Meltzer, Herbert, Potkin, Steven, Tiwari, Arun, Zai, Clement
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616325/ http://dx.doi.org/10.1093/ijnp/pyw041.389

Ejemplares similares

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2
por: Zai, Clement, et al.
Publicado: (2018)

PM493. Interactions of tardive dyskinesia with cognitive function in patients with schizophrenia: worsening of working memory with clozapine treatment
por: Kim, Soo In, et al.
Publicado: (2016)

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS
por: Maciukiewicz, Malgorzata, et al.
Publicado: (2018)

PM381. Reason for clozapine discontinuation
por: Cho, Jin-Woo, et al.
Publicado: (2016)

PM392. Clozapine-induced anemia and thrombocytosis
por: Jeon, Soyeon
Publicado: (2016)

PM415. Clozapine-induced anemia and thrombocytosis
por: Park, Hanson, et al.
Publicado: (2016)

PM422. Creatine Phospho Kinase Elevations with Clozapine
por: Takahashi, Yuka
Publicado: (2016)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

389 Choralgesange
por: Bach, Johann Sebastian

PM428. Combination of Clozapine with Long Acting Injectable Antipsychotics in Treatment Resistant Schizophrenia: Preliminary Evidence from Health Care Utilization Indices
por: Grimminck, Rachel, et al.
Publicado: (2016)

389. Pediatric Musculoskeletal Coccidioidomycosis in Central California: Single-Center Experience
por: Merriott, Daniel, et al.
Publicado: (2018)

PM412. Emergence of Tardive Dyskinesia upon Clozapine Treatment: A Case Report
por: Moon, Sun-Young, et al.
Publicado: (2016)

PM420. Additional clinical effects of long-term clozapine therapy for chronic schizophrenia
por: Seo, Young Eun, et al.
Publicado: (2016)

PM406. Urinary retention as a rare adverse effect of clozapine: a case report
por: Lin, Yi-Ting
Publicado: (2016)

PT613. The Role of SKA2 Genetic and Epigenetic Variation in Obsessive-Compulsive Disorder
por: Lisoway, Amanda J., et al.
Publicado: (2016)

EMB3/389: Information Systems for Evidence-based Healthcare: status, issues and perspectives
por: Jayaram, N
Publicado: (1999)

PM512. The effectiveness of clozapine in reducing medical costs associated with treatment-resistant schizophrenia in Japanese patients
por: Kikuchi, Yuka
Publicado: (2016)

PM418. Efficacy of Lurasidone in Patients With Schizophrenia With Prominent Positive Symptoms: A Pooled Analysis of Short-Term Placebo-Controlled Studies
por: Potkin, Steven G., et al.
Publicado: (2016)

389. Risk Factors and Outcomes of Patients with Infectious Complications After Surgical Treatment of Blount Disease
por: Polistico, Jordan, et al.
Publicado: (2019)

389. Epidemiology of Multiple Recurrent Clostridioides difficile in the Atlanta Metropolitan Area between 2016 and 2019
por: Fridkin, Scott, et al.
Publicado: (2022)

389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
por: Anosike, Brenda I, et al.
Publicado: (2023)

MON-389 Normotensive Pheochromocytoma
por: Babli, Saleha, et al.
Publicado: (2019)

PM450. Effects of olanzapine, clozapine, risperidone and sertindole on FGF2, synapsin and NGF expression in the hippocampus of naive mice
por: Ulak, Guner, et al.
Publicado: (2016)

Clozapine cessation
por: Ktari, H., et al.
Publicado: (2022)

PM527. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics
por: Melkersson, Kristina, et al.
Publicado: (2016)

Clozapine and urinary incontinence
por: Osca Oliver, A., et al.
Publicado: (2022)

PS29. Genetic of Antidepressant Response in Obsessive-Compulsive Disorder and Body Dysmorphic Disorder
por: Zai, Gwyneth, et al.
Publicado: (2016)

Genetics in schizophrenia: where are we and what next?
por: Tiwari, Arun K., et al.
Publicado: (2010)

PM427. Histamine H4 receptor is involved in clozapine-induced hematopoietic toxicity: vulnerability under granulocytic differentiation of HL-60 cells
por: Goto, Aya, et al.
Publicado: (2016)

M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
por: Yoshida, Kazunari, et al.
Publicado: (2020)

Monitoring sertraline and clozapine levels
por: Rodriguez Campos, A., et al.
Publicado: (2022)

Ethnic inequalities in treatment with clozapine
por: Fonseca De Freitas, D., et al.
Publicado: (2022)

Dealing With Clozapine-Induced Sialorrhea
por: Sá Couto, J., et al.
Publicado: (2022)

A database of 389 medicinal plants for diabetes
por: Babu, Padavala Ajay, et al.
Publicado: (2006)

P389: METHOTREXATE NEUROTOXICITY IN ADULT ALL
por: Levavi, Hannah, et al.
Publicado: (2023)

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis
por: Huang, Eric, et al.
Publicado: (2016)

T228. VARIABILITY AND UNDERUTILISATION OF CLOZAPINE IN SPAIN
por: Sanz-Fuentenebro, Francisco Javier, et al.
Publicado: (2018)

Mrna vaccination under clozapine treatment
por: Argitis, P., et al.
Publicado: (2022)

Clozapine placental passage at delivery: an update
por: Imaz, M.L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ja55il6vv92fbbd9nu8n879d75